Derek Alderson

9.4k total citations
127 papers, 4.6k citations indexed

About

Derek Alderson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Derek Alderson has authored 127 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Surgery, 68 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Derek Alderson's work include Esophageal Cancer Research and Treatment (56 papers), Gastric Cancer Management and Outcomes (39 papers) and Esophageal and GI Pathology (37 papers). Derek Alderson is often cited by papers focused on Esophageal Cancer Research and Treatment (56 papers), Gastric Cancer Management and Outcomes (39 papers) and Esophageal and GI Pathology (37 papers). Derek Alderson collaborates with scholars based in United Kingdom, Netherlands and Sweden. Derek Alderson's co-authors include Jane Blazeby, C P Barham, Jenny Donovan, Sally A. Norton, Sara Brookes, J R Farndon, Stephen Falk, Juan Ignacio Arrarás, John R. Farndon and Richard Hardwick and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Derek Alderson

122 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Derek Alderson 3.2k 2.5k 1.2k 579 382 127 4.6k
Joel H. Rubenstein 4.6k 1.4× 1.8k 0.7× 1.3k 1.1× 1.8k 3.0× 359 0.9× 175 6.7k
S M Griffin 5.7k 1.8× 4.7k 1.9× 1.0k 0.9× 1.2k 2.1× 268 0.7× 188 7.2k
Victor F. Trastek 4.4k 1.4× 5.2k 2.0× 1.7k 1.4× 942 1.6× 566 1.5× 119 8.6k
Elfriede Bollschweiler 4.9k 1.5× 4.3k 1.7× 1.4k 1.2× 913 1.6× 819 2.1× 195 7.1k
T. N. Walsh 2.7k 0.9× 2.1k 0.8× 525 0.4× 404 0.7× 268 0.7× 135 3.8k
Isao Miyashiro 2.8k 0.9× 3.5k 1.4× 2.1k 1.8× 1.1k 1.9× 773 2.0× 235 6.6k
Fabrizio Michelassi 4.1k 1.3× 1.4k 0.5× 2.8k 2.4× 445 0.8× 437 1.1× 160 7.8k
Christianne J. Buskens 3.9k 1.2× 979 0.4× 1.2k 1.0× 238 0.4× 253 0.7× 190 6.0k
Laith H. Jamil 1.5k 0.5× 816 0.3× 828 0.7× 540 0.9× 142 0.4× 112 2.8k
Lesley Anderson 2.0k 0.6× 938 0.4× 830 0.7× 538 0.9× 648 1.7× 155 4.6k

Countries citing papers authored by Derek Alderson

Since Specialization
Citations

This map shows the geographic impact of Derek Alderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Alderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Alderson more than expected).

Fields of papers citing papers by Derek Alderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Alderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Alderson. The network helps show where Derek Alderson may publish in the future.

Co-authorship network of co-authors of Derek Alderson

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Alderson. A scholar is included among the top collaborators of Derek Alderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Alderson. Derek Alderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reed, Michelle A.C., Christian Ludwig, Douglas G. Ward, et al.. (2017). Metabolomic Evidence for a Field Effect in Histologically Normal and Metaplastic Tissues in Patients with Esophageal Adenocarcinoma. Neoplasia. 19(3). 165–174. 15 indexed citations
2.
3.
Ercolani, Marco G., Ravinder Vohra, Fiona Carmichael, K. Mangat, & Derek Alderson. (2015). The lifetime cost to English students of borrowing to invest in a medical degree: a gender comparison using data from the Office for National Statistics. BMJ Open. 5(4). e007335–e007335. 13 indexed citations
4.
Vohra, Ravinder, Philip Spreadborough, Marianne Johnstone, et al.. (2015). Protocol for a multicentre, prospective, population-based cohort study of variation in practice of cholecystectomy and surgical outcomes (The CholeS study). BMJ Open. 5(1). e006399–e006399. 14 indexed citations
5.
Cunningham, David, Ruth E. Langley, Matthew Nankivell, et al.. (2015). LBA-03 Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). Annals of Oncology. 26. iv117–iv117. 7 indexed citations
6.
Søreide, Kjetil, Derek Alderson, Anders Bergenfelz, et al.. (2013). Strategies to improve clinical research in surgery through international collaboration. The Lancet. 382(9898). 1140–1151. 50 indexed citations
7.
Ford, Samuel, Peyman Obeidy, Matthew Bedford, et al.. (2012). Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. British Journal of Pharmacology. 168(6). 1316–1328. 70 indexed citations
8.
Jaiswal, Vikash, Sarah Ross, Deidre Wild, et al.. (2009). Abstracts of oral presentations to the ENT UK meeting, 5 September 2008, London, UK. The Journal of Laryngology & Otology. 123(5). 3 indexed citations
9.
Blazeby, Jane, et al.. (2004). Upper GI 01–12. British journal of surgery. 91(Supplement_1). 6–11. 5 indexed citations
10.
Newcomb, Paul V., M Moorghen, Jyoti Gupta, et al.. (2004). Insulin-like growth factor binding protein-3: relationship to the development of gastric pre-malignancy and gastric adenocarcinoma (United Kingdom). Cancer Causes & Control. 15(2). 211–218. 18 indexed citations
11.
Blazeby, Jane, Sara Brookes, & Derek Alderson. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut. 49(2). 227–230. 116 indexed citations
12.
Vickery, C W, Jane Blazeby, Thierry Conroy, et al.. (2001). Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. European Journal of Cancer. 37(8). 966–971. 149 indexed citations
13.
Blazeby, Jane, John R. Farndon, Jenny Donovan, & Derek Alderson. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 88(8). 1781–1787. 13 indexed citations
14.
Blazeby, Jane, John R. Farndon, Jenny Donovan, & Derek Alderson. (2000). A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 88(8). 1781–1787. 238 indexed citations
15.
Barham, C P, et al.. (1997). Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut. 41(2). 151–155. 33 indexed citations
16.
Hardwick, Richard, C P Barham, P.V. Newcomb, et al.. (1997). Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. European Journal of Surgical Oncology. 23(1). 30–35. 65 indexed citations
17.
Alderson, Derek. (1996). Longitudinal Muscle in Esophageal Disease. Gut. 38(5). 794.1–794. 7 indexed citations
18.
Barham, C P, D. C. Gotley, Angela M. Mills, & Derek Alderson. (1995). Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease.. Gut. 36(4). 505–510. 57 indexed citations
19.
Blazeby, Jane, et al.. (1995). Quality of life measurement in patients with oesophageal cancer.. Gut. 37(4). 505–508. 120 indexed citations
20.
Hardwick, Richard, Neil A. Shepherd, M Moorghen, P.V. Newcomb, & Derek Alderson. (1995). c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.. Journal of Clinical Pathology. 48(2). 129–132. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel H. Rubenstein Breakdown of academic impact, for papers by S M Griffin Breakdown of academic impact, for papers by Victor F. Trastek Breakdown of academic impact, for papers by Elfriede Bollschweiler Breakdown of academic impact, for papers by T. N. Walsh Breakdown of academic impact, for papers by Isao Miyashiro Breakdown of academic impact, for papers by Fabrizio Michelassi Breakdown of academic impact, for papers by Christianne J. Buskens Breakdown of academic impact, for papers by Laith H. Jamil Breakdown of academic impact, for papers by Lesley Anderson
Rankless by CCL
2026